Cochliobolus sativus

Overview

Description
An extract from Cochliobolus sativus used in allergy testing.
Description
An extract from Cochliobolus sativus used in allergy testing.
DrugBank ID
DB10433
Type
Biotech
US Approved
YES
Other Approved
NO
Clinical Trials
Phase 0
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Therapeutic Categories
  • Non-Standardized Fungal Allergenic Extract

Identification

Summary

Cochliobolus sativus is an extract from Cochliobolus sativus used in allergy testing.

Generic Name
Cochliobolus sativus
DrugBank Accession Number
DB10433
Background

Cochliobolus sativus is a fungus which can provoke allergic reactions. Cochliobolus sativus extract is used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Bipolaris sorokinianaInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Bipolaris sorokinianaInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Bipolaris sorokinianaSolution40000 [PNU]/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Bipolaris SorokinianaInjection, solution0.05 g/1mLPercutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Bipolaris sorokinianaInjection, solution10000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
A Mold MixtureCochliobolus sativus (0.0017 g/1mL) + Aspergillus flavus (0.0004 g/1mL) + Aspergillus fumigatus (0.0004 g/1mL) + Aspergillus niger var. niger (0.0004 g/1mL) + Aspergillus repens (0.0004 g/1mL) + Aureobasidium pullulans var. pullutans (0.0017 g/1mL) + Botrytis cinerea (0.0017 g/1mL) + Candida tropicalis (0.0008 g/1mL) + Chaetomium globosum (0.0017 g/1mL) + Epicoccum nigrum (0.0017 g/1mL) + Fusarium oxysporum (0.0017 g/1mL) + Geotrichum candidum (0.0017 g/1mL) + Mucor plumbeus (0.0006 g/1mL) + Mucor racemosus (0.0006 g/1mL) + Neurospora intermedia (0.0008 g/1mL) + Penicillium camemberti (0.0003 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0003 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0003 g/1mL) + Penicillium expansum (0.0003 g/1mL) + Penicillium italicum (0.0003 g/1mL) + Penicillium roqueforti (0.0003 g/1mL) + Phoma destructiva (0.0017 g/1mL) + Rhizopus stolonifer (0.0017 g/1mL) + Rhizopus stolonifer (0.0006 g/1mL) + Rhodotorula rubra (0.0017 g/1mL) + Saccharomyces cerevisiae (0.0017 g/1mL)Injection, solutionIntradermal; SubcutaneousAntigen Laboratories, Inc.1974-03-23Not applicableUS flag
A Mold MixtureCochliobolus sativus (0.0067 g/1mL) + Aspergillus flavus (0.0017 g/1mL) + Aspergillus fumigatus (0.0017 g/1mL) + Aspergillus niger var. niger (0.0017 g/1mL) + Aspergillus repens (0.0017 g/1mL) + Aureobasidium pullulans var. pullutans (0.0067 g/1mL) + Botrytis cinerea (0.0067 g/1mL) + Candida tropicalis (0.0033 g/1mL) + Chaetomium globosum (0.0067 g/1mL) + Epicoccum nigrum (0.0067 g/1mL) + Fusarium oxysporum (0.0067 g/1mL) + Geotrichum candidum (0.0067 g/1mL) + Mucor plumbeus (0.0022 g/1mL) + Mucor racemosus (0.0022 g/1mL) + Neurospora intermedia (0.0033 g/1mL) + Penicillium camemberti (0.0011 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0011 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0011 g/1mL) + Penicillium expansum (0.0011 g/1mL) + Penicillium italicum (0.0011 g/1mL) + Penicillium roqueforti (0.0011 g/1mL) + Phoma destructiva (0.0067 g/1mL) + Rhizopus stolonifer (0.0067 g/1mL) + Rhizopus stolonifer (0.0022 g/1mL) + Rhodotorula rubra (0.0067 g/1mL) + Saccharomyces cerevisiae (0.0067 g/1mL)Injection, solutionIntradermal; SubcutaneousAntigen Laboratories, Inc.1992-04-13Not applicableUS flag
A Mold MixtureCochliobolus sativus (0.0033 g/1mL) + Aspergillus flavus (0.0008 g/1mL) + Aspergillus fumigatus (0.0008 g/1mL) + Aspergillus niger var. niger (0.0008 g/1mL) + Aspergillus repens (0.0008 g/1mL) + Aureobasidium pullulans var. pullutans (0.0033 g/1mL) + Botrytis cinerea (0.0033 g/1mL) + Candida tropicalis (0.0017 g/1mL) + Chaetomium globosum (0.0033 g/1mL) + Epicoccum nigrum (0.0033 g/1mL) + Fusarium oxysporum (0.0033 g/1mL) + Geotrichum candidum (0.0033 g/1mL) + Mucor plumbeus (0.0011 g/1mL) + Mucor racemosus (0.0011 g/1mL) + Neurospora intermedia (0.0017 g/1mL) + Penicillium camemberti (0.0006 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0006 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0006 g/1mL) + Penicillium expansum (0.0006 g/1mL) + Penicillium italicum (0.0006 g/1mL) + Penicillium roqueforti (0.0006 g/1mL) + Phoma destructiva (0.0033 g/1mL) + Rhizopus stolonifer (0.0033 g/1mL) + Rhizopus stolonifer (0.0011 g/1mL) + Rhodotorula rubra (0.0033 g/1mL) + Saccharomyces cerevisiae (0.0033 g/1mL)Injection, solutionIntradermal; SubcutaneousAntigen Laboratories, Inc.1974-03-23Not applicableUS flag
AHH Mold MixCochliobolus sativus (13333.333 [PNU]/1mL) + Alternaria alternata (13333.333 [PNU]/1mL) + Cladosporium sphaerospermum (13333.333 [PNU]/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
AHH Mold MixCochliobolus sativus (0.0166 g/1mL) + Alternaria alternata (0.0166 g/1mL) + Cladosporium sphaerospermum (0.0166 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
3LN5B70U4W
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910602
RxNav
852398
Wikipedia
Cochliobolus_sativus

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntradermal; Subcutaneous
Injection, solutionIntradermal; Subcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
Injection, solutionPercutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.01 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous10000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous20000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous40000 [PNU]/1mL
Injection, solutionIntradermal1000 [PNU]/1mL
Injection, solutionPercutaneous0.10 g/1mL
Injection, solutionSubcutaneous0.001 g/1mL
Injection, solutionSubcutaneous10000 [PNU]/1mL
Injection, solutionSubcutaneous20000 [PNU]/1mL
Injection, solutionSubcutaneous40000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous0.025 g/1mL
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
InjectionCutaneous; Intradermal; Subcutaneous0.1 g/1mL
Injection, solutionPercutaneous; Subcutaneous1 g/20mL
Injection, solutionSubcutaneous
SolutionIntradermal; Percutaneous; Subcutaneous
Injection, solutionPercutaneous; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53